Lesson plan

Tilmetamine

Tilmetamine is a dissociative drug of the arylcyclohexylamine family related to tiletamine. It is the analogue of tiletamine in which the N-ethyl group has been replaced with an N-methyl group. The drug is said to be 3 to 5 times more potent than ketamine and to have a longer duration. It is reported to produce adverse effects, such as blurred vision. Tilmetamine is expected to act as an NMDA receptor antagonist similarly to tiletamine and ketamine. It was encountered as a novel designer drug online in August 2024.

Back to article

Article summary

Tilmetamine is a dissociative drug of the arylcyclohexylamine family related to tiletamine. It is the analogue of tiletamine in which the N-ethyl group has been replaced with an N-methyl group. The drug is said to be 3 to 5 times more potent than ketamine and to have a longer duration. It is reported to produce adverse effects, such as blurred vision. Tilmetamine is expected to act as an NMDA receptor antagonist similarly to tiletamine and ketamine. It was encountered as a novel designer drug online in August 2024.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.